OR16-02 Histone ADP-Ribosylation Site Mutations As Oncogenic Drivers In Breast And Ovarian Cancers

Disclosure: D. Huang: None. C.V. Camacho: None. A. Nagari: None. W.L. Kraus: Other; Self; - Founder and stockholder for Ribon Therapeutics, Inc. - Founder, stockholder, scientific advisory board member, member of the board of directors for ARase Therapeutics, Inc. - Coholder of U.S. Patent. Recent s...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Dan, Camacho, Cristel V, Nagari, Anusha, Lee Kraus, W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554411/
http://dx.doi.org/10.1210/jendso/bvad114.2194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554411/
http://dx.doi.org/10.1210/jendso/bvad114.2194

Ejemplares similares